Sign in

CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company

DBV Technologies S.A.

Sign in to watch
Ticker
DBVTF
Exchange
Nasdaq, OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
France
Entity type
operating
Phone
330155427878
Business address
107 AVENUE DE LA REPUBLIQUE, CHATILLON, France

Securities

  • DBVT American Depositary Shares Nasdaq
  • DBVTF Common stock OTC
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 8-K Event Results of operations
  3. 10-Q Report Quarterly Report
  4. 8-K Event Other events
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 4 Open-market sale Chief Medical Officer sold 464 shares at $2.70 ($1,253)
  8. S-3ASR Offering Registration Statement
  9. 8-K Event Results of operations
  10. 10-Q Report Quarterly Report
  11. 8-K Event Other events
  12. 8-K Event Executive or director change
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. ARS Other Annual Report to Security Holders
  20. DEF 14A Proxy Proxy Statement

Page 1 of 29 · 577 filings